Hyperglycaemia as part of the stress response: the underlying mechanisms

Best Practice and Research: Clinical Anaesthesiology

Volumn 23, Issue 4, 2009, Pages 375-386

  Van Cromphaut, S J ^a  

^a LABORATORY OF MOLECULAR AND CELLULAR SIGNALING   (Belgium)

Author keywords

critical illness; cytokines; glucose metabolism; insulin; insulin resistance; insulin therapy; stress hormones; stress hyperglycaemia

Indexed keywords

ALPHA INTERFERON; AUTACOID; CARBOHYDRATE; CORTICOSTEROID; CORTICOTROPIN RELEASING FACTOR; GLUCAGON; GLUCOKINASE; GLUCOSE; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 2; GLUCOSE TRANSPORTER 4; GLYCOGEN; GROWTH HORMONE; HEXOKINASE; HYDROCORTISONE; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; INTERLEUKIN 1; INTERLEUKIN 2; INTERLEUKIN 6; PHENYTOIN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); PROTEIN KINASE B; PROTEINASE INHIBITOR; STRESS HORMONE; THIAZIDE DIURETIC AGENT; TUMOR NECROSIS FACTOR;

ADRENERGIC SYSTEM; AGING; BED REST; CARBOHYDRATE METABOLISM; CENTRAL NERVOUS SYSTEM; CLINICAL FEATURE; CRITICAL ILLNESS; DIABETES MELLITUS; DISEASE EXACERBATION; ENERGY EXPENDITURE; GLUCONEOGENESIS; GLUCOSE TRANSPORT; GLUCOSE UTILIZATION; GLYCOGEN SYNTHESIS; HEART OUTPUT; HUMAN; HYPERGLYCEMIA; HYPOKALEMIA; INHIBITION KINETICS; INSULIN RESISTANCE; LIVER CIRRHOSIS; LIVER PARENCHYMA; PANCREATITIS; PRIORITY JOURNAL; REVIEW; SKELETAL MUSCLE; STRESS; TOTAL PARENTERAL NUTRITION; VASOCONSTRICTION;

ANIMALS; BLOOD GLUCOSE; CRITICAL ILLNESS; HUMANS; HYPERGLYCEMIA; INFLAMMATION MEDIATORS; INSULIN; INSULIN RESISTANCE; MUSCLE, SKELETAL; SIGNAL TRANSDUCTION; STRESS, PSYCHOLOGICAL;

EID: 70649088951     PISSN: 15216896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpa.2009.08.005     Document Type: Review

References (98)

1. Pessin J.E., and Saltiel A.R. Signaling pathways in insulin action: molecular targets of insulin resistance. Journal of Clinical Investigation 106 (2000) 165-169
2. Bone R.C., Sprung C.L., and Sibbald W.J. Definitions for sepsis and organ failure. Critical Care Medicine 20 (1992) 724-726
3. Cerra F.B. Hypermetabolism, organ failure, and metabolic support. Surgery 101 (1987) 1-14
4. Van den Berghe G., Wouters P., Weekers F., et al. Intensive insulin therapy in the critically ill patients. New England Journal of Medicine 345 (2001) 1359-1367
5. Van den Berghe G., Wilmer A., Hermans G., et al. Intensive insulin therapy in the medical ICU. New England Journal of Medicine 354 (2006) 449-461
6. Vlasselaers D., Milants I., Desmet L., et al. Intensive insulin therapy for patients in paediatric intensive care: a prospective, randomised controlled study. Lancet 373 (2009) 547-556
7. Van den Berghe G., Schetz M., Vlasselaers D., et al. Intensive insulin therapy in critically ill patients: NICE-SUGAR or Leuven blood glucose target?. Journal of Clinical Endocrinology & Metabolism 94 (2009) 3163-3170
8. Finfer S., Chittock D.R., Su S.Y., et al. Intensive versus conventional glucose control in critically ill patients. New England Journal of Medicine 360 (2009) 1283-1297
9. Brunkhorst F.M., Engel C., Bloos F., et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. New England Journal of Medicine 358 (2008) 125-139
10. Baron A.D., Brechtel G., Wallace P., et al. Rates and tissue sites of non-insulin- and insulin-mediated glucose uptake in humans. American Journal of Physiology 255 (1988) E769-E774
11. Shepherd P.R., and Kahn B.B. Glucose transporters and insulin action-implications for insulin resistance and diabetes mellitus. New England Journal of Medicine 341 (1999) 248-257
12. Pessin J.E., and Bell G.I. Mammalian facilitative glucose transporter family: structure and molecular regulation. Annual Review of Physiology 54 (1992) 911-930
13. Wolfe R.R. Sepsis as a modulator of adaptation to low and high carbohydrate and low and high fat intakes. European Journal of Clinical Nutrition 53 Suppl. 1 (1999) S136-S142
14. Stumvoll M., Chintalapudi U., Perriello G., et al. Uptake and release of glucose by the human kidney. Postabsorptive rates and responses to epinephrine. Journal of Clinical Investigation 96 (1995) 2528-2533
15. Mizock B.A. Alterations in fuel metabolism in critical illness: hyperglycaemia. Best Practice and Research Clinical Endocrinology and Metabolism 15 (2001) 533-551
16. Shulman R.G., Bloch G., and Rothman D.L. In vivo regulation of muscle glycogen synthase and the control of glycogen synthesis. Proceedings of the National Academic Science USA 92 (1995) 8535-8542
17. Gerich J.E. Control of glycaemia. Baillière's Clinical Endocrinology and Metabolism 7 (1993) 551-586
18. Stumvoll M., Meyer C., Mitrakou A., et al. Renal glucose production and utilization: new aspects in humans. Diabetologia 40 (1997) 749-757
19. Niijima A. Neural mechanisms in the control of blood glucose concentration. The Journal of Nutrition 119 (1989) 833-840
20. Iynedjian P.B. Molecular physiology of mammalian glucokinase. Cellular and Molecular Life Sciences 66 (2009) 27-42
21. Moore M.C., Connolly C.C., and Cherrington A.D. Autoregulation of hepatic glucose production. European Journal of Endocrinology 138 (1998) 240-248
22. Tappy L., Chiolero R., and Berger M. Autoregulation of glucose production in health and disease. Current Opinion in Clinical Nutrition and Metabolic Care 2 (1999) 161-164
23. Rossetti L., Giaccari A., Barzilai N., et al. Mechanism by which hyperglycemia inhibits hepatic glucose production in conscious rats. Implications for the pathophysiology of fasting hyperglycemia in diabetes. The Journal of Clinical Investigation 92 (1993) 1126-1134
24. Hue L. The role of futile cycles in the regulation of carbohydrate metabolism in the liver. Advances in Enzymology and Related Areas of Molecular Biology 52 (1981) 247-331
25. Tappy L., Cayeux M.C., Schneiter P., et al. Effects of lactate on glucose metabolism in healthy subjects and in severely injured hyperglycemic patients. American Journal of Physiology 268 (1995) E630-E635
26. Shulman G.I., Lacy W.W., Liljenquist J.E., et al. Effect of glucose, independent of changes in insulin and glucagon secretion, on alanine metabolism in the conscious dog. Journal of Clinical Investigation 65 (1980) 496-505
27. Frayn K.N., Little R.A., Maycock P.F., et al. The relationship of plasma catecholamines to acute metabolic and hormonal responses to injury in man. Circulation Shock 16 (1985) 229-240
28. Barton R.N. Neuroendocrine mobilization of body fuels after injury. British Medical Bulletin 41 (1985) 218-225
29. Frayn K.N. Hormonal control of metabolism in trauma and sepsis. Clinical Endocrinology (Oxford) 24 (1986) 577-599
30. Preissig C.M., and Rigby M.R. Hyperglycaemia results from beta-cell dysfunction in critically ill children with respiratory and cardiovascular failure: a prospective observational study. Critical Care 13 (2009) R27
31. Siegel J.H., Cerra F.B., Coleman B., et al. Physiological and metabolic correlations in human sepsis. Invited commentary. Surgery 86 (1979) 163-193
32. Miyoshi H., Shulman G.I., Peters E.J., et al. Hormonal control of substrate cycling in humans. Journal of Clinical Investigation 81 (1988) 1545-1555
33. Wolfe R.R. Substrate utilization/insulin resistance in sepsis/trauma. Baillière's Clinical Endocrinology and Metabolism 11 (1997) 645-657
34. Lang C.H., Dobrescu C., and Bagby G.J. Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose output. Endocrinology 130 (1992) 43-52
35. Petit F., Bagby G.J., and Lang C.H. Tumor necrosis factor mediates zymosan-induced increase in glucose flux and insulin resistance. American Journal of Physiology 268 (1995) E219-E228
36. Flores E.A., Istfan N., Pomposelli J.J., et al. Effect of interleukin-1 and tumor necrosis factor/cachectin on glucose turnover in the rat. Metabolism 39 (1990) 738-743
37. Sakurai Y., Zhang X.J., and Wolfe R.R. TNF directly stimulates glucose uptake and leucine oxidation and inhibits FFA flux in conscious dogs. American Journal of Physiology 270 (1996) E864-E872
38. Koivisto V.A., Pelkonen R., and Cantell K. Effect of interferon on glucose tolerance and insulin sensitivity. Diabetes 38 (1989) 641-647
39. Lang C.H., Molina P.E., Yousef K.A., et al. Role of IL-1 alpha in central nervous system immunomodulation of glucoregulation. Brain Research 624 (1993) 53-60
40. Petit F., Jarrous A., Dickinson R.D., et al. Contribution of central and peripheral adrenergic stimulation to IL-1 alpha-mediated glucoregulation. American Journal of Physiology 267 (1994) E49-E56
41. Mehta V.K., Hao W., Brooks-Worrell B.M., et al. Low-dose interleukin 1 and tumor necrosis factor individually stimulate insulin release but in combination cause suppression. European Journal of Endocrinology 130 (1994) 208-214
42. Chrousos G.P. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. New England Journal of Medicine 332 (1995) 1351-1362
43. Hager P., Permert J., Wikstrom A.C., et al. Preoperative glucocorticoid administration attenuates the systemic stress response and hyperglycemia after surgical trauma in the rat. Metabolism 58 (2009) 449-455
44. Wolfe R.R., Durkot M.J., Allsop J.R., et al. Glucose metabolism in severely burned patients. Metabolism 28 (1979) 1031-1039
45. Thorell A., Rooyackers O., Myrenfors P., et al. Intensive insulin treatment in critically ill trauma patients normalizes glucose by reducing endogenous glucose production. Journal of Clinical Endocrinology & Metabolism 89 (2004) 5382-5386
46. Kellum J.A., Kramer D.J., Lee K., et al. Release of lactate by the lung in acute lung injury. Chest 111 (1997) 1301-1305
47. Curtis S.E., and Cain S.M. Regional and systemic oxygen delivery/uptake relations and lactate flux in hyperdynamic, endotoxin-treated dogs. American Review of Respiratory Disease 145 (1992) 348-354
48. Haji-Michael P.G., Ladriere L., Sener A., et al. Leukocyte glycolysis and lactate output in animal sepsis and ex vivo human blood. Metabolism 48 (1999) 779-785
49. Wilmore D.W., Goodwin C.W., Aulick L.H., et al. Effect of injury and infection on visceral metabolism and circulation. Annals of Surgery 192 (1980) 491-504
50. Felig P., Pozefsky T., Marliss E., et al. Alanine: key role in gluconeogenesis. Science 167 (1970) 1003-1004
51. Roh M.S., Moldawer L.L., Ekman L.G., et al. Stimulatory effect of interleukin-1 upon hepatic metabolism. Metabolism 35 (1986) 419-424
52. Wolfe R.R. Carbohydrate metabolism in the critically ill patient. Implications for nutritional support. Critical Care Clinics 3 (1987) 11-24
53. McGuinness O.P., Fugiwara T., Murrell S., et al. Impact of chronic stress hormone infusion on hepatic carbohydrate metabolism in the conscious dog. American Journal of Physiology 265 (1993) E314-E322
54. Stumvoll M., Perriello G., Meyer C., et al. Role of glutamine in human carbohydrate metabolism in kidney and other tissues. Kidney International 55 (1999) 778-792
55. Shangraw R.E., Jahoor F., Miyoshi H., et al. Differentiation between septic and postburn insulin resistance. Metabolism 38 (1989) 983-989
56. Marik P.E., and Raghavan M. Stress-hyperglycemia, insulin and immunomodulation in sepsis. Intensive Care Medicine 30 (2004) 748-756
57. Aljada A., Ghanim H., Assian E., et al. Tumor necrosis factor-alpha inhibits insulin-induced increase in endothelial nitric oxide synthase and reduces insulin receptor content and phosphorylation in human aortic endothelial cells. Metabolism 51 (2002) 487-491
58. Nunes A.L., Carvalheira J.B., Carvalho C.R., et al. Tissue-specific regulation of early steps in insulin action in septic rats. Life Sciences 69 (2001) 2103-2112
59. Gao Z., Hwang D., Bataille F., et al. Serine phosphorylation of insulin receptor substrate 1 by inhibitor kappa B kinase complex. The Journal of Biologicl Chemistry 277 (2002) 48115-48121
60. Barnes P.J., and Karin M. Nuclear factor-kappa B: a pivotal transcription factor in chronic inflammatory diseases. New England Journal of Medicine 336 (1997) 1066-1071
61. Chiasson J.L., Shikama H., Chu D.T., et al. Inhibitory effect of epinephrine on insulin-stimulated glucose uptake by rat skeletal muscle. The Journal of Clinical Investigation 68 (1981) 706-713
62. Haring H., Kirsch D., Obermaier B., et al. Decreased tyrosine kinase activity of insulin receptor isolated from rat adipocytes rendered insulin-resistant by catecholamine treatment in vitro. Biochemical Journal 234 (1986) 59-66
63. Lang C.H. Sepsis-induced insulin resistance in rats is mediated by a beta-adrenergic mechanism. American Journal of Physiology 263 (1992) E703-E711
64. Dimitriadis G., Leighton B., Parry-Billings M., et al. Effects of glucocorticoid excess on the sensitivity of glucose transport and metabolism to insulin in rat skeletal muscle. Biochemical Journal 321 Pt 3 (1997) 707-712
65. Smith T.R., Elmendorf J.S., David T.S., et al. Growth hormone-induced insulin resistance: role of the insulin receptor, IRS-1, GLUT-1, and GLUT-4. American Journal of Physiology 272 (1997) E1071-E1079
66. Dominici F.P., Cifone D., Bartke A., et al. Alterations in the early steps of the insulin-signaling system in skeletal muscle of GH-transgenic mice. American Journal of Physiology 277 (1999) E447-E454
67. Maitra S.R., Wojnar M.M., and Lang C.H. Alterations in tissue glucose uptake during the hyperglycemic and hypoglycemic phases of sepsis. Shock 13 (2000) 379-385
68. Meszaros K., Lang C.H., Bagby G.J., et al. Tumor necrosis factor increases in vivo glucose utilization of macrophage-rich tissues. Biochemicl and Biophysical Research Community 149 (1987) 1-6
69. Bird T.A., Davies A., Baldwin S.A., et al. Interleukin 1 stimulates hexose transport in fibroblasts by increasing the expression of glucose transporters. The Journal of Biologicl Chemistry 265 (1990) 13578-13583
70. Vary T.C., Drnevich D., Jurasinski C., et al. Mechanisms regulating skeletal muscle glucose metabolism in sepsis. Shock 3 (1995) 403-410
71. Wolfe R.R., Jahoor F., Herndon D.N., et al. Isotopic evaluation of the metabolism of pyruvate and related substrates in normal adult volunteers and severely burned children: effect of dichloroacetate and glucose infusion. Surgery 110 (1991) 54-67
72. Hotchkiss R.S., and Karl I.E. Reevaluation of the role of cellular hypoxia and bioenergetic failure in sepsis. Journal of the American Medical Association 267 (1992) 1503-1510
73. Vary T.C., Siegel J.H., Nakatani T., et al. Regulation of glucose metabolism by altered pyruvate dehydrogenase activity. I. Potential site of insulin resistance in sepsis. JPEN Journal of Parenteral and Enteral Nutrition 10 (1986) 351-355
74. Shangraw R.E., Jahoor F., Wolfe R.R., et al. Pyruvate dehydrogenase inactivity is not responsible for sepsis-induced insulin resistance. Critical Care Medicine 24 (1996) 566-574
75. Saeed M., Carlson G.L., Little R.A., et al. Selective impairment of glucose storage in human sepsis. British Journal of Surgery 86 (1999) 813-821
76. del Aguila L.F., Claffey K.P., and Kirwan J.P. TNF-alpha impairs insulin signaling and insulin stimulation of glucose uptake in C2C12 muscle cells. American Journal of Physiology 276 (1999) E849-E855
77. Fan J., Li Y.H., Wojnar M.M., et al. Endotoxin-induced alterations in insulin-stimulated phosphorylation of insulin receptor, IRS-1, and MAP kinase in skeletal muscle. Shock 6 (1996) 164-170
78. Kelley D.E., Mokan M., Simoneau J.A., et al. Interaction between glucose and free fatty acid metabolism in human skeletal muscle. The Journal of Clinical Investigation 92 (1993) 91-98
79. Suikkari A.M., Koivisto V.A., Rutanen E.M., et al. Insulin regulates the serum levels of low molecular weight insulin-like growth factor-binding protein. The Journal of Clinical Endocrinology and Metabolism 66 (1988) 266-272
80. Mesotten D., Delhanty P.J., Vanderhoydonc F., et al. Regulation of insulin-like growth factor binding protein-1 during protracted critical illness. The Journal of Clinical Endocrinology and Metabolism 87 (2002) 5516-5523
81. Wolfe R.R., and Burke J.F. Glucose and lactate metabolism in experimental septic shock. American Journal of Physiology 235 (1978) R219-R227
82. McCowen K.C., Ling P.R., Ciccarone A., et al. Sustained endotoxemia leads to marked down-regulation of early steps in the insulin-signaling cascade. Critical Care Medicine 29 (2001) 839-846
83. Iynedjian P.B. Mammalian glucokinase and its gene. Biochemical Journal 293 Pt 1 (1993) 1-13
84. Baud V., and Karin M. Signal transduction by tumor necrosis factor and its relatives. Trends in Cell Biology 11 (2001) 372-377
85. Hirosumi J., Tuncman G., Chang L., et al. A central role for JNK in obesity and insulin resistance. Nature 420 (2002) 333-336
86. Xu J., Kim H.T., Ma Y., et al. Trauma and hemorrhage-induced acute hepatic insulin resistance: dominant role of tumor necrosis factor-alpha. Endocrinology 149 (2008) 2369-2382
87. Rosmarin D.K., Wardlaw G.M., and Mirtallo J. Hyperglycemia associated with high, continuous infusion rates of total parenteral nutrition dextrose. Nutrition in Clinical Practice 11 (1996) 151-156
88. Pagliassotti M.J., and Cherrington A.D. Regulation of net hepatic glucose uptake in vivo. Annual Review of Physiology 54 (1992) 847-860
89. Mesotten D., Swinnen J.V., Vanderhoydonc F., et al. Contribution of circulating lipids to the improved outcome of critical illness by glycemic control with intensive insulin therapy. The Journal of Clinical Endocrinology and Metabolism 89 (2004) 219-226
90. Mesotten D., Wouters P.J., Peeters R.P., et al. Regulation of the somatotropic axis by intensive insulin therapy during protracted critical illness. The Journal of Clinical Endocrinology and Metabolism 89 (2004) 3105-3113
91. Langouche L., Vander Perre S., Wouters P.J., et al. Effect of intensive insulin therapy on insulin sensitivity in the critically ill. The Journal of Clinical Endocrinology and Metabolism 92 (2007) 3890-3897
92. Vanhorebeek I., De Vos R., Mesotten D., et al. Protection of hepatocyte mitochondrial ultrastructure and function by strict blood glucose control with insulin in critically ill patients. Lancet 365 (2005) 53-59
93. Nygren J., Thorell A., Efendic S., et al. Site of insulin resistance after surgery: the contribution of hypocaloric nutrition and bed rest. Clinical Science (London) 93 (1997) 137-146
94. Soop M., Nygren J., Thorell A., et al. Preoperative oral carbohydrate treatment attenuates endogenous glucose release 3 days after surgery. Clinical Nutrition 23 (2004) 733-741
95. Van Cromphaut S.J., Vanhorebeek I., and Van den Berghe G. Glucose metabolism and insulin resistance in sepsis. Current Pharmaceutical Design 14 (2008) 1887-1899
96. Langouche L., Vanhorebeek I., Vlasselaers D., et al. Intensive insulin therapy protects the endothelium of critically ill patients. The Journal of Clinical Investigation 115 (2005) 2277-2286
97. Langouche L., Meersseman W., Vander Perre S., et al. Effect of insulin therapy on coagulation and fibrinolysis in medical intensive care patients. Critical Care Medicine 36 (2008) 1475-1480
98. Vanhorebeek I., Peeters R.P., Vander Perre S., et al. Cortisol response to critical illness: effect of intensive insulin therapy. The Journal of Clinical Endocrinology and Metabolism 91 (2006) 3803-3813